Plasma Beta-endorphin Levels and Suicidal Behavior

NANot yet recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
SuicideDepressionBeta Endorphin
Interventions
BIOLOGICAL

Blood samples

Blood samples will be collected at both visit between 8:30 a.m. and 9:30 a.m. and fasting from midnight.

OTHER

questionnaires

"Questionnaires will be administrated at both visits to assess the suicide spectrum, the depression level and some personality traits.~Hetero-questionnaires will be administrated during a clinical interview conducted by a psychiatrist or psychologist at the inclusion.~* MINI 7.0 Mini-International Neuropsychiatric Interview :~* MADRS (Montgomery Asberg Depression Scale)~* C-SSRS (Columbia-Suicide Severity Rating Scale)~* FAST (Functioning Assessment Short Test)~Self-administered questionnaire will be completed by the participant at the inclusion and at the end of hospitalisation (D7+/- 2 days) :~* STAI-Y (State-Trait Anxiety Inventory )~* PPP-VAS (Visual Analog Scale to measure Psychological and Physical Pain)~* SHAPS (Snaith-Hamilton-Pleasure Scale )~* CTQ (Childhood Trauma Questionnaire)~* ESUL : Echelle de solitude de l'université de Laval~* BIS-11 : (Barratt Impulsiveness Scale)~* QIDS (Quick Inventory of Depressive Symptomatology)"

Trial Locations (1)

34295

University hospital, Montpellier

All Listed Sponsors
collaborator

Institut de Génomique Fonctionnelle (IGF) de Montpellier

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT06291467 - Plasma Beta-endorphin Levels and Suicidal Behavior | Biotech Hunter | Biotech Hunter